Clinical Trial Update: CMV Modulation of the Immune System in ANCA-associated Vasculitis [Phase 2]

View source ↗

Summary

This update covers a Phase 2 trial investigating CMV modulation of the immune system in ANCA-associated vasculitis. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Cytomegalovirus Infection

Snippet

Sponsor: Professor Lorraine Harper | Conditions: ANCA Associated Vasculitis, CMV Infection | Phase 2 | Status: UNKNOWN